LifeMD, Inc. (LFMD)

NASDAQ: LFMD · Real-Time Price · USD
6.08
+0.07 (1.16%)
At close: Sep 17, 2025, 4:00 PM EDT
6.09
+0.01 (0.16%)
After-hours: Sep 17, 2025, 7:54 PM EDT
1.16%
Market Cap288.30M
Revenue (ttm)245.56M
Net Income (ttm)-9.03M
Shares Out 47.42M
EPS (ttm)-0.21
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,254,768
Open5.99
Previous Close6.01
Day's Range5.99 - 6.25
52-Week Range3.99 - 15.84
Beta1.57
AnalystsBuy
Price Target12.50 (+105.59%)
Earnings DateNov 6, 2025

About LFMD

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications,... [Read more]

Sector Healthcare
Founded 1994
Employees 307
Stock Exchange NASDAQ
Ticker Symbol LFMD
Full Company Profile

Financial Performance

In 2024, LifeMD's revenue was $212.45 million, an increase of 39.27% compared to the previous year's $152.55 million. Losses were -$21.99 million, -7.23% less than in 2023.

Financial Statements

Analyst Summary

According to 6 analysts, the average rating for LFMD stock is "Buy." The 12-month stock price target is $12.5, which is an increase of 105.59% from the latest price.

Price Target
$12.5
(105.59% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against LifeMD, Inc. (LFMD)

NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of N...

5 hours ago - GlobeNewsWire

Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman

SAN FRANCISCO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executi...

15 hours ago - GlobeNewsWire

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LifeMD To Contact Him Directly To Discuss Their Options If you suff...

4 days ago - PRNewsWire

Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements – Hagens Berman

SAN FRANCISCO, Sept. 12, 2025 (GLOBE NEWSWIRE) -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executi...

5 days ago - GlobeNewsWire

Shareholders who lost money in shares of LifeMD, Inc. (NASDAQ: LFMD) Should Contact Wolf Haldenstein Immediately

NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP is notifying investors about a federal securities class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) (“Life...

9 days ago - GlobeNewsWire

Berger Montague PC Investigates Securities Claims Against LifeMD, Inc. (NASDAQ: LFMD)

PHILADELPHIA , Sept. 4, 2025 /PRNewswire/ -- Berger Montague PC , national plaintiffs' law firm, announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on beh...

13 days ago - PRNewsWire

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LifeMD To Contact Him Directly To Discuss Their Options

20 days ago - GlobeNewsWire

LifeMD to Participate in Three Investor Conferences During September

NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following inv...

20 days ago - GlobeNewsWire

LifeMD: The Dip Could Deepen, Valuation More Attractive

LifeMD saw year-over-year revenue growth for its second quarter slow markedly from the comparable figure in the first quarter. Gross profit margins dipped 200 basis points, versus its year-ago period,...

4 weeks ago - Seeking Alpha

LFMD Investors Have Opportunity to Join LifeMD, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)---- $LFMD--LFMD Investors Have Opportunity to Join LifeMD, Inc. Fraud Investigation with the Schall Law Firm.

4 weeks ago - Business Wire

LifeMD, Inc. Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses

4 weeks ago - GlobeNewsWire

LifeMD, Inc. (LFMD) Q2 2025 Earnings Call Transcript

LifeMD, Inc. (NASDAQ:LFMD) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman & CEO Marc Benathen - Chief Financial Officer Conference Call Pa...

Other symbols: LFMDP
6 weeks ago - Seeking Alpha

LifeMD Reports Second Quarter 2025 Results

Total revenue increased 23% year-over-year to $62.2 million; adjusted EBITDA rose 223% to $7.1 million Telehealth revenue increased 30% to $48.6 million; telehealth adjusted EBITDA rose 560% to $3.4 m...

6 weeks ago - GlobeNewsWire

Medifast Announces Second Quarter 2025 Financial Results

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter...

Other symbols: MED
6 weeks ago - Business Wire

LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the Canaccord Genuity 45th Annual Gro...

Other symbols: LFMDP
6 weeks ago - GlobeNewsWire

LifeMD Names COO and Promotes Two Executives

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services, today announced the appointment of Shayna Webb Dray as its Chief Operating O...

6 weeks ago - GlobeNewsWire

LifeMD: Inflection Into Profitability Should Drive Stock Upward

LifeMD is a fast-growing, profitable telehealth company with strong partnerships, a robust tech stack and a valuable SaaS asset. The Novo Nordisk/Hims fallout is bullish, not bearish, for LifeMD. Novo...

2 months ago - Seeking Alpha

LifeMD: An Overlooked GLP-1 Beneficiary

LifeMD has evolved through multiple rebrandings, now offering 24/7 virtual primary and urgent care access to patients. The company operates RexMD, a men's telehealth platform, serving around 500,000 c...

3 months ago - Seeking Alpha

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend...

Other symbols: LFMDP
3 months ago - GlobeNewsWire

LifeMD to Participate in Two Investor Conferences During June

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following inv...

3 months ago - GlobeNewsWire

LifeMD: Growth, Growth, And More Growth

LifeMD is experiencing a major growth inflection, with record Q1 revenue, first-ever GAAP profitability, and strong subscriber and margin gains. Multiple growth drivers - including GLP-1 programs, Med...

3 months ago - Seeking Alpha

Top 2 Health Care Stocks That May Implode In Q2

As of May 23, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Other symbols: HAFN
4 months ago - Benzinga

LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®

Bundled Offer Includes Wegovy® at $199 and LifeMD's Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month Thereafter Bundled Offer Includes Wegovy® at $199 and LifeMD's Virt...

Other symbols: LFMDP
4 months ago - GlobeNewsWire

LifeMD to Participate in Three Investor Conferences During May

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following inve...

Other symbols: LFMDP
4 months ago - GlobeNewsWire

LifeMD, Inc. (LFMD) Q1 2025 Earnings Call Transcript

LifeMD, Inc. (NASDAQ:LFMD) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman and CEO Marc Benathen - Chief Financial Officer Conference Call Par...

Other symbols: LFMDP
4 months ago - Seeking Alpha